Large-scale population-based clinical studies and further experimental studies are needed to elucidate the exact effect and potential biological mechanisms of Gal-9 in the pathogenesis of CAD and to evaluate whether Gal-9 is a potential novel biomarker of CAD. Here, LGALS9 is linked to coronary artery disorder.